Investigation of the Effect of Hyperbaric Oxygen Therapy in Patients With Avascular Necrosis
NCT ID: NCT07142018
Last Updated: 2025-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
20 participants
OBSERVATIONAL
2025-08-19
2025-08-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hyperbaric oxygen therapy is a treatment method used in patients with avascular necrosis.
Avascular necrosis can significantly affect the quality of life of patients. The aim of this study was to investigate the effects of hyperbaric oxygen therapy on physical capacity, depressive symptoms, and quality of life in patients diagnosed with avascular necrosis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Hyperbaric Oxygen Therapy on Microcirculation
NCT03980210
Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications
NCT07240649
Angiogenesis Induced in the Elderly by Hyperbaric Oxygen Therapy
NCT02790541
Effects of HBO Therapy on Muscular Insulin Resistence in Type 2 Diabetes
NCT01472328
Hyperbaric Oxygen Treatment as Adjuvant Treatment for Frost Injury
NCT01270477
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hyperbaric oxygen therapy is a treatment method used in patients with avascular necrosis. In hyperbaric oxygen therapy, patients breathe 100% oxygen under high pressure. This treatment can help treat avascular necrosis by increasing oxygen, promoting new blood vessel formation, reducing inflammation, and facilitating cell repair mechanisms.
Avascular necrosis can significantly affect the quality of life of patients. The effects of avascular necrosis on quality of life can be summarized as follows: Avascular necrosis often causes severe pain and limited mobility in the joint areas. These physical symptoms can prevent patients from performing their daily activities, leading to social isolation and a decline in overall quality of life.
The aim of this study was to investigate the effects of hyperbaric oxygen therapy on physical capacity, depressive symptoms, and quality of life in patients diagnosed with avascular necrosis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with Avascular Necrosis
Patients with Avascular Necrosis Undergone Hyperbaric Oxgen
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Receive hyperbaric treatment,
* Be diagnosed with avascular necrosis,
* Have stage 1-2 avascular necrosis according to the Ficat classification,
* Be able to understand and speak Turkish,
* Be able to read and write,
Exclusion Criteria
* Having cardio-respiratory failure that prevents walking,
* Having a disorder related to the musculoskeletal system other than AVN
* Having a diagnosis of avascular necrosis classified as stage 3-4 according to the Ficat classification
* Presence of varicose veins,
* Presence of urinary stress incontinence,
* Presence of systemic or rheumatological disease,
* Pregnancy,
* Refusal to participate in the study.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Lutfi Kirdar Kartal Training and Research Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
İsmail Koç
Assistant Prof
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kartal Dr Lutfi Kirdar City Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ismail Koc
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.